TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bristol-Myers Squibb AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,479,462
|
2,892,362
|
2,506,068 |
| Financial expenses |
37,533
|
9,180
|
6,916 |
| Earnings before taxes |
0
|
191,483
|
111,759 |
| EBITDA |
4,619
|
204,953
|
122,456 |
| Total assets |
1,340,183
|
2,139,969
|
1,396,175 |
| Current assets |
1,325,779
|
2,120,254
|
1,368,683 |
| Current liabilities |
646,317
|
1,547,545
|
925,148 |
| Equity capital |
692,639
|
589,190
|
464,950 |
| - share capital |
6,585
|
6,148
|
6,339 |
| Employees (average) |
164
|
160
|
153 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
51.7%
|
27.5%
|
33.3% |
| Turnover per employee |
21,216
|
18,077
|
16,380 |
| Profit as a percentage of turnover |
0%
|
6.6%
|
4.5% |
| Return on assets (ROA) |
2.8%
|
9.4%
|
8.5% |
| Current ratio |
205.1%
|
137.0%
|
147.9% |
| Return on equity (ROE) |
0%
|
32.5%
|
24.0% |
| Change turnover |
381,867
|
461,612
|
66,481 |
| Change turnover % |
12%
|
19%
|
3% |
| Chg. No. of employees |
4
|
7
|
21 |
| Chg. No. of employees % |
3%
|
5%
|
16% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.